Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fipexide is a small molecule that was formerly marketed as a nootropic drug, intended to improve cognitive functions by potentially modulating dopaminergic neurotransmission. However, its pharmaceutical use was discontinued due to severe adverse effects, including fulminant hepatic failure and drug fever. More recently, fipexide has been identified as a novel chemical inducer in plant biotechnology, promoting callus formation and shoot regeneration in various plant species through mechanisms distinct from traditional plant hormones like auxin and cytokinin. It has also been predicted as a potential drug candidate to overcome melphalan-induced vascular toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fipexide.